Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
Interactive cardiovascular and thoracic surgery Jul, 2009 | Pubmed ID: 19380336